Checkpoint immunotherapy rejects primary tumors without cDC1 cells or lasting immune memory
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
A new study has revealed that immune checkpoint blockade can drive the first wave of tumor rejection even when a ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine